Literature DB >> 33812449

Diversity, geographical distribution, and prevalence of Entamoeba spp. in Brazil: a systematic review and meta-analysis.

Andernice Dos Santos Zanetti1, Antonio Francisco Malheiros1, Tatiane Amorim de Matos1, Carolina Dos Santos1, Paula Franciene Battaglini2, Luciana Melhorança Moreira3, Larissa Maria Scalon Lemos4, Solange Kimie Ikeda Castrillon1, Denise da Costa Boamorte Cortela5, Eliane Ignotti1, Omar Ariel Espinosa6.   

Abstract

The genus Entamoeba includes a variety of widely distributed species adapted to live in the digestive tracts of humans and a large variety of animals of different classes. The objective of this study was to investigate the prevalence, distribution, and molecular epidemiology of Entamoeba spp. in different classes of hosts in Brazil. Studies that analyzed hosts from several classes, including humans and domestic, wild, or captive animals, were considered. The pooled prevalence of Entamoeba spp. was calculated using the random-effects model. A total of 166 studies on humans and 16 on animals were included. The prevalence of Entamoeba spp. in the Brazilian population was 22% (95% CI: 21-24). The state with the highest prevalence was Paraiba with 72%, followed by Federal District with 53%, and Rondonia with 50%. In immunocompromized patients, the prevalence was 18%, and cancer (36%) was the most prevalent cause of immunosuppression. The prevalence of Entamoeba spp. in animal hosts was 12% (95% CI: 7-17). Captive wild animals and domestic farm animals showed the highest prevalence, with 16% and 15%, respectively. The species found more often were E. coli (86.5%), E. dispar (7.9%), and E. histolytica (3.1%). In conclusion, a high prevalence (22%) of Entamoeba spp. was found in the Brazilian population, with a prevalence of up to 50% mainly in the northern, northeastern, and central-western regions. The pathogenic species E. histolytica is distributed in most Brazilian regions, with significant prevalence percentages. Among animals, unidentified Entamoeba species were most prevalent in mammals. © A.S. Zanetti et al., published by EDP Sciences, 2021.

Entities:  

Keywords:  Amebiasis; Diarrhea; Parasitic disease; Protozoan; Zoonoses

Mesh:

Year:  2021        PMID: 33812449      PMCID: PMC8019558          DOI: 10.1051/parasite/2021028

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


Introduction

The genus Entamoeba includes a variety of anaerobic, unicellular, and monoxenic protozoan species adapted to live as parasites or commensals in the digestive tracts of humans and a large variety of animals of different classes [5, 7, 64, 110, 112, 205, 206]. The main species of this genus that parasitize humans are E. histolytica, E. dispar, E. moshkovskii, E. coli, E. polecki, E. bangladeshi, and E. hartmanni [84, 124, 151, 174]. Morphologically, the species E. histolytica, E. dispar, and E. moshkovskii are considered identical, but only E. histolytica is the causative agent of amebiasis, a gastrointestinal disease that commonly occurs worldwide; amebiasis is considered endemic in tropical regions and is associated with inadequate socioeconomic and sanitary conditions [8, 166, 216]. Entamoeba histolytica shows several degrees of virulence and is capable of invading a wide variety of tissues in the host, including those of the colon and liver, and more rarely the lung, skin, urogenital tract, brain, and spleen. This invasive feature separates it from the other species [70]. It is estimated that amebiasis accounts for 55 500 all-age deaths and causes disability-adjusted life years at 2.237 million [211]. In contrast, E. dispar can cause focal intestinal lesions in laboratory animals [133]. However, in humans, it is considered a stable commensal with no virulent characteristics, producing an asymptomatic carrier state and being generally much more prevalent worldwide than E. histolytica [64, 124]. On the other hand, the idea that E. dispar is a simple commensal parasite is under discussion, and some authors discuss the importance of this species in damage of the intestine and liver [73]. Globally, the overall prevalence of Entamoeba spp. in humans is 3.5%. Entamoeba histolytica and E. dispar account for 81.7% of this global prevalence in documented infections. The comparison of prevalence by regions showed differences in prevalence between Australia (1.7%) and North America (21.6%) [64]. Regarding zoonotic potential, research on E. histolytica, E. dispar, E. hartmanni, E. coli, E. moshkovskii, and E. polecki is remarkably important because of previous reports on these species in both humans and different species of animals worldwide [76, 110, 152, 165, 206]. Furthermore, regarding pathogenic potential, some of these species can cause diarrhea and other symptomatic presentations in non-human primates [165]. The Entamoeba spp. have a variety of vertebrate hosts: E. moshkovskii is found in cattle, elephants, and reptiles [94, 110]; E. coli and E. hartmanni are found in non-human primates [26, 57, 113, 220]; and finally, some studies suggest that different subtypes of E. polecki, infect human, non-human primates, pigs and ostriches [41, 59, 76, 84, 112]. In Brazil, several studies based on microscopic examination have investigated the prevalence of amebiasis in different population groups, but discriminatory studies between species (using molecular methods) are relatively scarce and mainly address different animal hosts. Although there are data on the prevalence of Entamoeba spp. in some regions, there is no aggregate analysis of the prevalence and distribution of species of this protozoan by geographic area, sex, age group, and host type in Brazil. Therefore, the objective of this systematic review and meta-analysis was to determine the prevalence and distribution of different species of Entamoeba in several host classes in Brazil.

Materials and methods

The protocol of this systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO 2019: CRD42020167222) before its implementation. The protocol and final report were developed according to the Cochrane Handbook for Systematic Reviews of Interventions [105].

The review question

What is the prevalence and geographical distribution of Entamoeba spp. in different host species in Brazil?

Inclusion and exclusion criteria

This review included studies on various hosts (humans and domestic, wild, or captive animals) of different classes to determine the prevalence and genetic identification of Entamoeba spp. in Brazil through coprological analyses and molecular techniques. Studies analyzing fecal samples of humans and domestic, wild, or captive animals that did not report percentages of samples positive for Entamoeba spp. were excluded.

Types of studies

This review included cross-sectional epidemiological studies assessing the prevalence of Entamoeba spp. in humans and wild, captive, and domestic animals.

Search strategy

An initial search limited to MEDLINE was conducted using MeSH index terms and related keywords. Subsequently, the words contained in the title, abstract, and index terms used to describe the articles were analyzed. A second search using all identified keywords and index terms was performed using all included databases. As a source of gray literature, a search was conducted in the reference lists of dissertations and theses that evaluated the prevalence of protozoan intestinal parasites. Because this search was limited to Brazil, it was limited to studies in the English, Spanish, and Portuguese languages. This search had no start date limitation but was completed in November 2020. The studies were searched in the following databases: Spanish Bibliographic Index of Health Sciences (IBECS), Latin American and Caribbean Literature in Health Sciences (LILACS), Virtual Health Library (BVS), US National Library of Medicine bibliographic database (Medline), Elsevier database EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, Cochrane Library, and National Institute of Health and Clinical Excellence (NICE). The MeSH index terms searched were Entamoeba and Brazil. The keywords Brasil and Endamoeba were also included in the search. The MeSH terms and keywords were combined via the boolean operators “AND” and/or “OR” to compose the search strings.

Assessment of methodological quality

The articles selected for data retrieval were analyzed by two independent reviewers to evaluate the methodological validity of each text before inclusion in this review. The quality of the publications included was evaluated based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Studies received one point for not presenting a study design or execution limitations (risk of bias), inconsistency of results, indirectness of evidence, imprecision, and publication bias. A score of 4–5 points was considered high quality, 3 as moderate quality, and 0–2 as low quality.

Data extraction

The selected texts were evaluated by two independent reviewers for validity before inclusion; discrepancies were resolved by an independent reviewer. The data were entered into the Review Manager (RevMan 5.3) [168] software for analysis. A data extraction table was used to evaluate the quality of demographic data, study location, sample size, number of cases, number of positive cases, and diagnostic test.

Data summary

The random-effects meta-analysis model was used to analyze the overall combined prevalence of Entamoeba spp. in humans and animals. The heterogeneity among studies was evaluated using I2-statistic, which shows the percentage of variation among studies. These analyses were performed using the Stata software, version 12.

Results

Our systematic literature search yielded 1694 manuscripts using the established search strategies. As per the eligibility criteria (after exclusion of duplicate texts and articles related to other topics and exclusion of text based on review criteria or owing to method quality), 182 studies were selected for analysis (Table 1) [2–4, 6, 7, 9–25, 27–37, 39, 40, 42–45, 47–56, 58, 60–63, 65–69, 71, 72, 74, 75, 77–83, 85–93, 95–104, 106–109, 111, 114–123, 125–130, 132, 135, 136, 138–140, 142–146, 148–150, 153–164, 167, 169–173, 175–192, 194–204, 207–210, 212–215, 217–219]. Of these studies, 166 evaluated the prevalence of Entamoeba spp. in human fecal samples from different Brazilian states during different periods; the remaining 16 studies analyzed the prevalence of Entamoeba spp. parasites in different wild, captive, and domestic animals. Of the 182 studies included, 9 identified the species of the genus Entamoeba by molecular characterization, 17 by serology, and 2 by isoenzyme analysis. The results of this search strategy are presented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) flowchart (Fig. 1). Data were extracted according to the PRISMA Statement [141].
Table 1

A summary of the included studies.

No.RegionCity – StateTotal NPrevalence (%)Diagnostic methodAuthor/year
Human host
1MidwestCaceres – MT539.4CAlencar et al. [7]
2MidwestCampo Novo do Parecis – MT4337.2CZenazokenae et al. [219]
3MidwestCaceres – MT18336.6CSilva et al. [196]
4MidwestRondonopolis – MT21511.5CLuz et al. [125]
5MidwestParque do Xingu – MT30452.9CEscobar-Pardo et al. [77]
6MidwestMT17316.8CCoimbra Jr and Santos [60]
7MidwestParque Xingu – MT6275.8CFerreira et al. [87]
8MidwestMirassol D’Oeste – MT14938.2CLatorraca et al. [118]
9MidwestCorumba – MS20052.0CSilva et al. [198]
10MidwestCorumba – MS19655.1CSilva et al. [197]
11MidwestCampo Grande – MS5104.6CCurval et al. [65]
12MidwestCampo Grande – MS6625.7CHiga Júnior et al. [104]
13MidwestMS10343.7CNeres-Norberg et al. [150]
14MidwestBonito – MS11523.5CGomes et al. [97]
15MidwestSidrolandia – MS31364.8CAguiar et al. [4]
16MidwestDF7553.3CPereira et al. [157]
17MidwestCumari – GO10292.7CBorges et al. [33]
18SouthMoreira Sales – PR424.8CBarbosa and Pavanelli [20]
19SouthMaringa – PR15016.0CColli et al. [61]
20SouthCampo Mourao – PR52197.2CMortean et al. [144]
21SouthMaria Helena – PR4316.5CSantos and Merlini [177]
22SouthCascavel – PR34317.8CTakizawa et al. [207]
23SouthUbirata – PR864.6CFalavigna et al. [79]
24SouthCampo Mourao – PR864.6CKulik et al. [117]
25SouthJataizinho – PR26426.9CLopes et al. [122]
26SouthPitanga – PR18120.9CNascimento and Moitinho [149]
27SouthMaringa – PR3695.9CGuilherme et al. [101]
28SouthPorto Alegre – PR17,95115.1CDe Carli et al. [69]
29SouthPelotas – RS7335.6CJeske et al. [111]
30SouthIpe – RS1244.0CZanotto et al. [218]
31SouthPalmeiras das Missoes – RS20920.6CNagel et al. [148]
32SouthCaxias do Sul – RS2571.5CCamello et al. [44]
33SouthCaxias do Sul – RS3313.3CPorto et al. [162]
34SouthFlores da Cunha – RS3413.2CCavagnolli et al. [53]
35SouthRio Grande – RS14428.5CMata-Santos et al. [136]
36SouthPorto Alegre – RS14610.3CSilva et al. [192]
37SouthCaxias do Sul – RS978714.6CBasso et al. [22]
38SouthPorto Alegre – RS18114.9CBencke et al. [24]
39SouthCampos Novos – SC10913.7CBiolchi et al. [28]
40SouthFlorianopolis – SC31263.5CBueno et al. [40]
41SouthFlorianopolis – SC5731.6CSantos et al. [180]
42SouthBlumenau – SC5318.9CAndrade et al. [11]
43SouthCriciuma – SC9456.4ESchnack et al. [185]
44SouthFlorianopolis – SC434.6CKorzeniowski et al. [116]
45NortheastTeresina – PI39,5398.4CIbiapina et al. [108]
46NortheastBurti dos Lopes – PI5118.4CSousa et al. [201]
47NortheastParnaiba – PI25129.9CFernandes et al. [85]
48NortheastSao Raimundo Nonato – PI26542.6CAlves et al. [10]
49NortheastSanta Cruz – RN34802.3CLima et al. [121]
50NortheastAracaju – SE47631.3COliveira et al. [155]
51NortheastAracaju – SE50032.6CRollemberg et al. [172]
52NortheastAracaju – SE29814.1C and ELawson et al. [119]
53NortheastSanto Antonio de Jesus – BA14445.8CReis et al. [167]
54NortheastSalvador – BA48,0280.5C and MSoares et al. [200]
55NortheastSanto Antonio de Jesus – BA14445.8CAndrade et al. [12]
56NortheastAiquara – BA23615.7CSantos et al. [183]
57NortheastFeira de Santana – BA34950.1CAlmeida et al. [9]
58NortheastIlheus – BA9749.5C and ESantos et al. [181]
59NortheastSalvador – BA20065.0CSeixas et al. [186]
60NortheastSalvador – BA52,7043.4C and MSantos et al. [178]
61NortheastSalvador – BA562415.6CSantos et al. [176]
62NortheastIpira – BA41012.2CSantos-Junior et al. [184]
63NortheastCuite – PB4540.0CBezerra et al. [27]
64NortheastJoao Pessoa – PB15018.6CMonteiro et al. [143]
65NortheastCampina Grande – PB119569.0C and ESilva et al. [195]
66NortheastJoao Pessoa – PB6728.3CMagalhães et al. [129]
67NortheastCampina Grande – PB74293.1CSilva et al. [188]
68NortheastRussas – CE21321.6C and MCalegar et al. [43]
69NortheastFortaleza – CE58229.4CBachur et al. [15]
70NortheastFortaleza – CE73538.3C and EBraga et al. [36]
71NortheastFortaleza – CE16120.5EBraga et al. [35]
72NortheastFortaleza – CE56436.2C and EBraga et al. [34]
73NortheastMaceio – AL10036.4C and MSantos et al. [182]
74NortheastMaceio – AL17983.8C and EDuarte et al. [74]
75NortheastRecife – PE2134.7C and EDourado et al. [72]
76NortheastRecife e Macaparana – PE17835.8C and MPinheiro et al. [159]
77NortheastMacaparana – PE14372.6C and MPinheiro et al. [158]
78NortheastRecife, Palmares e Bodoco – PE63328.3C, Z and EAca et al. [3]
79NortheastSao Lourenço da Mata – PE48541.2C and EGonçalves et al. [98]
80NortheastRecife – PE45950.9EOkazaki et al. [153]
81NortheastChapadinha – MA393326.9CSilva et al. [190]
82Northeast, NorthTimo – MA, Macapa – AP10,2603.8CFerraz et al. [86]
83NorthBelem – PA3203.7CCarvalho et al. [50]
84NorthSantarem – PA36734.3CBanhos et al. [16]
85NorthBelem – PA33428.4C and ESilva et al. [187]
86NorthBelem – PA43828.9EPóvoa et al. [163]
87NorthPA30057.6CMiranda et al. [140]
88NorthPresidente Figueiredo – AM1434.2CGonçalves et al. [99]
89NorthCoari – AM659.2CSilva et al. [194]
90NorthSanta Izabel do Rio Negro – AM46325.3CValverde et al. [215]
91NorthManaus – AM40040.5COliveira et al. [154]
92NorthIauarete – AM33331.2CBoia et al. [32]
93NorthManaus – AM45123.9CMaia et al. [130]
94NorthCoari – AM21129.4CMonteiro et al. [142]
95NorthCoari – AM12321.1CSilva et al. [189]
96NorthSao Gabriel da Cachoeira – AM89529.9CRios et al. [170]
97NorthSanta Izabel do Rio Negro – AM30871.7CBoia et al. [31]
98NorthEirunepe – AM41338.2CAraújo and Fernandez [13]
99NorthManaus – AM158537.3C and EBenetton et al. [25]
100NorthNova Olinda do Norte – AM8123.4CHurtado-Guerrero et al. [106]
101NorthNovo Airao – AM31629.1CBoia et al. [30]
102NorthManaus – AM1109.1CGiugliano et al. [96]
103NorthAriquemes e Monte Negro – RO21650.4C and ESantos et al. [179]
104NorthAcrelandia – AC42925.6CSouza et al. [202]
105SoutheastDiamantina – MG6618.2CEustachio et al. [78]
106SoutheastBelo Horizonte – MG62896.5C and MCosta et al. [62]
107SoutheastViçosa – MG41932.9CIasbik et al. [107]
108SoutheastAlfenas – MG2772.5CFelizardo et al. [83]
109SoutheastItuiutaba – MG14022.1CMoura et al. [146]
110SoutheastSete Lagoas – MG2630.8CPires et al. [160]
111SoutheastUberaba – MG13236.4CCabrine-Santos et al. [42]
112SoutheastCaldas – MG6066.6Simões et al. [199]
113SoutheastDivinopolis – MG14035.7C and EPereira et al. [156]
114SoutheastMG40989.7CAssis et al. [14]
115SoutheastUberaba – MG8263.4MCembranelli et al. [54]
116SoutheastOuro verde de minas – MG31528.2CCarvalho et al. [49]
117SoutheastUberlandia – MG11017.3CFerreira-Filho et al. [89]
118SoutheastViçosa – MG2464.1CEinloft et al. [75]
119SoutheastPato de Minas – MG16116.1CSilva and Silva [191]
120SoutheastBerilo – MG14924.8CMartins et al. [135]
121SoutheastVespasiano – MG17616.5CBarçante et al. [21]
122SoutheastUberlandia – MG16023.1CMachado et al. [127]
123SoutheastAbadia dos Dourados – MG37620.5CMachado et al. [128]
124SoutheastBelo Horizonte – MG47214.6CMenezes et al. [138]
125SoutheastVespasiano – MG5376.3CSantos et al. [175]
126SoutheastBambui – MG28117.4CRocha et al. [171]
127SoutheastUberlandia – MG2641.5CRezende et al. [169]
128SoutheastUberlandia – MG10424.0CCosta-Cruz et al. [63]
129SoutheastUberlandia – MG10062.0CFavoreto Jr and Machado [82]
130SoutheastSao Mateus – ES5036.0CAlbuquerque and Souza [6]
131SoutheastSao Matheus – ES4219.0CBrauer et al. [39]
132SoutheastSao Mateus – ES22131.2CDamázio et al. [67]
133SoutheastSao Mateus – ES8231.7CDamázio et al. [66]
134SoutheastSumidouro – RJ29412.9CBarbosa et al. [19]
135SoutheastRio de Janeiro – RJ32456.8CFaria et al. [81]
136SoutheastRio de Janeiro – RJ59512.2CIgnácio et al. [109]
137SoutheastRio de Janeiro – RJ18010.5Valença-Barbosa et al. [214]
138SoutheastNiteroi – RJ6817.6CLeite et al. [120]
139SoutheastNiteroi – RJ17495.4CMacedo et al. [126]
140SoutheastNiteroi – RJ42911.6CUchôa et al. [213]
141SoutheastRio de Janeiro – RJ2181.4CCarvalho-Costa et al. [51]
142SoutheastNiteroi – RJ14015.7CPort-Lourenço et al. [161]
143SoutheastNiteroi – RJ26121.8CUchôa et al. [212]
144SoutheastRJ9931.3CMoura et al. [145]
145SoutheastRibeirao Preto – SP23313.3CFonseca et al. [91]
146SoutheastSao Jose do Rio Preto – SP1007.0CCastro et al. [52]
147SoutheastCampos do Jordao – SP18522.2CBranco et al. [37]
148SoutheastMirassol – SP31015.1CBelloto et al. [23]
149SoutheastSao Jose do Rio Preto – SP5000.8CCardoso et al. [48]
150SoutheastSao Paulo – SP6640.9CLopes et al. [123]
151SoutheastCatanduva – SP1339.7CBiscegli et al. [29]
152SoutheastPresidente Bernardes – SP1018.9CTashima et al. [209]
153SoutheastRibeirao Preto – SP4299.3CCapuano et al. [47]
154SoutheastAraraquara – SP50314.5CMiné and Rosa [139]
155SoutheastSao Paulo – SP12016.6CKorkes et al. [115]
156SoutheastCatanduva – SP25034.4CFaleiros et al. [80]
157SoutheastPresidente Prudente – SP10007.1CTashima and Simões [208]
158SoutheastSao Paulo – SP20013.0CCimerman et al. [58]
159SoutheastSao Jose da Bela Vista – SP10320.2CTavares-Dias and Grandini [210]
160SoutheastBotucatu – SP14722.4CGuimarães and Sogayar [102]
161SoutheastHolambra – SP22215.7CKobayashi et al. [114]
162SoutheastSao Paulo – SP4071.5CFerreira et al. [88]
163SoutheastOsasco – SP15521.3ZAca et al. [2]
164SoutheastSao Paulo – SP39525.8CGuerra et al. [100]
165SoutheastGuarulhos – SP91321.9CChieffi et al. [56]
166SoutheastRibeirao Preto – SP135123.1CFerriolli-Filho [90]
Animal host
167SoutheastRio de Janeiro – RJ13 (bird – emu)23.1C and MGallo et al. [93]
168SoutheastRio de Janeiro – RJ1190 (non-human primate)33.4CBarbosa et al. [18]
169SoutheastPetropolis – RJ790 (pig)21.5CBarbosa et al. [17]
170SoutheastSao Paulo – SP21 (rodent – mouse)9.5CChagas et al. [55]
171SoutheastBauru – SP47 (non-human primate)23.4CDavid et al. [68]
172SoutheastBotucatu – SP207 (bird)1.9CMarietto-Gonçalves et al. [132]
173SoutheastSao Paulo – SP31 (canid – guara wolf)22.6CGilioli and Silva [95]
174SoutheastSao Paulo – SP103 (edentate – anteater)4.8CDiniz et al. [71]
175NortheastCE – MA – PI – PE – BA340 (dog)3.8CZanetti et al. [217]
176NortheastAracaju – SE44 (rodent – mouse)2.3CGuimarães et al. [103]
177NortheastLajes – RN64 (sheep)17.2CSouza et al. [203]
178NortheastItabuna – BA119 (dog)0.8CCampos-Filho et al. [45]
179NortheastRecife – PE685 (bird)5.7CFreitas et al. [92]
180NorthSena Madureira – AC18 (bird)22.2CSouza et al. [204]
181MidwestCaceres – MT120 (dog)15.8CRosales and Malheiros [173]
182SouthSC217 (goat)1.8CRadavelli et al. [164]

Abbreviations: MT – Mato Grosso; PR – Parana; PI – Piaui; RN – Rio Grande do Norte; PA – Para; MG – Minas Gerais; SE – Sergipe; BA – Bahia; MS – Mato Grosso do Sul; ES – Espirito Santo; RJ – Rio de Janeiro; PB – Paraiba; RS – Rio Grande do Sul; SP – Sao Paulo; CE – Ceara; AL – Alagoas; SC – Santa Catarina; DF – Federal District (capital of Brazil); MA – Maranhao; AP – Amapa; AM – Amazonas; RO – Rondonia; GO – Goias; AC – Acre; PE – Pernambuco. C – conventional method, based on detection by optical microscopy; M – molecular method, based on DNA detection; E – Elisa method, serology-based; Z – zymodema method, based on isoenzyme analysis.

Figure 1

A flowchart of the steps performed in the systematic review.

A flowchart of the steps performed in the systematic review. A summary of the included studies. Abbreviations: MT – Mato Grosso; PR – Parana; PI – Piaui; RN – Rio Grande do Norte; PA – Para; MG – Minas Gerais; SE – Sergipe; BA – Bahia; MS – Mato Grosso do Sul; ES – Espirito Santo; RJ – Rio de Janeiro; PB – Paraiba; RS – Rio Grande do Sul; SP – Sao Paulo; CE – Ceara; AL – Alagoas; SC – Santa Catarina; DF – Federal District (capital of Brazil); MA – Maranhao; AP – Amapa; AM – Amazonas; RO – Rondonia; GO – Goias; AC – Acre; PE – Pernambuco. C – conventional method, based on detection by optical microscopy; M – molecular method, based on DNA detection; E – Elisa method, serology-based; Z – zymodema method, based on isoenzyme analysis. Regarding the methodological quality, according to the GRADE criteria used, all 166 studies evaluating the prevalence of Entamoeba spp. in different Brazilian populations as well as the 16 studies evaluating its prevalence in different animal host species presented a high methodological quality, all with a score of 5.

Entamoeba spp. in the Brazilian population

Overall, the 166 studies on human samples included 268,465 coprological tests and 114 from the oral cavity, including samples from 24 Brazilian states and the Federal District. The only states not analyzed were Roraima and Tocantins, both in the northern region. Test distribution by state showed that 10 studies were performed in Bahia (representing 40.2% of the analyzed samples), 4 in Piaui (15.1%), 11 in Rio Grande do Sul (11.0%), 25 in Minas Gerais (6.1%), 10 in Parana (4.0%), 22 in Sao Paulo (3.3%), 11 in Rio de Janeiro (2.7%), 15 in Amazonas (2.2%), 6 in Pernambuco (1.9%), 6 in Santa Catarina (1.3%), 5 in Ceara (0.8%), 5 in Paraiba (0.8%), 5 in Para (0.6%), 7 in Mato Grosso do Sul (0.6%), 3 in Sergipe (0.5%), 8 in Mato Grosso (0.4%), and 4 in Espirito Santo (0.2%). Two studies were conducted in the states of Maranhao (1.6% of the included samples) and Alagoas (1.0%). Only one study was conducted in Amapa (3.7%), Rio Grande do Norte (1.3%), Goias (0.4%), Acre (0.2%), Rondonia (0.1%), and the Federal District (0.03%). Of the 166 studies analyzed, only 19 distributed patient samples by sex, totaling 56,442 samples, of which 65% were female and 35% male, with 1992 (3.5%) positive samples. Of the positive samples, 1082 (54.3%) were from females and 910 (45.7%) from males. Fifty-six studies distributed the samples by age group, totaling 35,411 samples. Of these samples, 26,143 (73.8%) were from children aged 0–9 years; 5971 (16.8%) from aged 10–19 years, and 3297 (9.4%) from adults aged over 19 years. Of these samples, 5684 (16.1%) were positive for Entamoeba spp., with 4133 (72.7%) from children aged 0–9 years, 609 (10.8%) from 10–19 years, and 942 (16.5%) from adults over 19 years. Regarding the status of the immune system, 266,794 (99.3%) of the samples were from patients with no previously reported compromized immune system, whereas 1785 (0.7%) samples were from immunocompromized patients. Regarding the causes of immunosuppression, it was found that 1463 (82%) samples were from human immunodeficiency virus (HIV) carriers, 249 (14%) from patients undergoing hemodialysis, and 73 (4%) from patients with cancer. Of the samples from immunosuppressed patients, 338 (19%) were positive for Entamoeba spp.; 284 (84%) of these patients had HIV, 28 (8.3%) were undergoing hemodialysis, and 26 (7.7%) had cancer.

Pooled prevalence of Entamoeba spp.

The prevalence of Entamoeba spp. reported in the analyzed studies was between 0.2% and 93.1%. Random-effects meta-analysis showed a pooled prevalence of 22% (95% CI: 21–24; weight 100%) of Entamoeba spp. in the Brazilian population (Fig. 2).
Figure 2

Forest plot for a random-effect meta-analysis of the pooled prevalence of Entamoeba spp. in the Brazilian population by state. In parentheses the studies used for each state.

Forest plot for a random-effect meta-analysis of the pooled prevalence of Entamoeba spp. in the Brazilian population by state. In parentheses the studies used for each state. The analysis of pooled prevalence by state showed that it was 72% in Paraiba, 53% in the Federal District, 50% in Rondonia, 35% in Mato Grosso do Sul, 34% in Mato Grosso and Amazonas and Ceara, 31% in Espirito Santo, 30% in Para, 28% in Sergipe, 26% in Acre, 19% in Maranhao, 16% in Pernambuco, 15% in Rio Grande do Sul, 12% in Minas Gerais, 11% in Sao Paulo, 9% in Parana, Piaui and Rio de Janeiro, 6% in Santa Catarina, 4% in Alagoas and Amapa, 3% in Bahia and Goias, and 2% in Rio Grande do Norte (Fig. 2). The pooled prevalence with complete 95% CI values for each state is shown in Table 2.
Table 2

Distribution of the pooled prevalence of Entamoeba spp. according to state and age.

Overall
≤9
10–19
>20
StateOverall prevalence95% CIWeight (%)Prevalence95% CIWeight (%)Prevalence95% CIWeight (%)Prevalence95% CIWeight (%)
PR131–254.30131–257.16
SE3127–361.443127–362.39
RS207–335.63152–29 7.133626–475.19
PA 3430–391.433430–392.38
MG3322–4524.58239–3622.364524–67 41.1477–10021.17
SP1913–2612.891710–2414.313428–4110.492119–2310.72
MT286–505.66346–627.1094–205.28
MA43–61.4543–62.41
AP43–41.4543–42.42
SC3613–584.063613–586.79
PB8584–872.98584–874.82
BA3017–426.3139–164.185028–726.992016–2510.50
AM2014–269.88168–249.493022–3910.182621–3210.56
MS5636–765.505545–642.297565–8310.115144–5710.48
RJ 2217–272.742116–27 2.382615–405.12
PE238–395.72520–302.3965–721.133528–415.31
ES1910–331.331910–335.16
FD5342–641.345342–645.18
PI3025–361.423025–365.33
Overall Prevalence2924–341002518–311004029–501003420–47100

Abbreviations: 95% CI, 95% confidence interval. PR – Parana, SE – Sergipe, RS – Rio Grande do Sul, PA – Para, MG – Minas Gerais, SP – Sao Paulo, MT – Mato Grosso, MA – Maranhao, AP – Amapa, SC – Santa Catarina, PB – Paraiba, BA – Bahia, AM – Amazonas, MS, Mato Grosso do Sul, RJ – Rio de Janeiro, PE – Pernambuco, ES – Espirito Santo, DF – Federal District, PI – Piaui.

Distribution of the pooled prevalence of Entamoeba spp. according to state and age. Abbreviations: 95% CI, 95% confidence interval. PR – Parana, SE – Sergipe, RS – Rio Grande do Sul, PA – Para, MG – Minas Gerais, SP – Sao Paulo, MT – Mato Grosso, MA – Maranhao, AP – Amapa, SC – Santa Catarina, PB – Paraiba, BA – Bahia, AM – Amazonas, MS, Mato Grosso do Sul, RJ – Rio de Janeiro, PE – Pernambuco, ES – Espirito Santo, DF – Federal District, PI – Piaui. Pooled prevalence by age group showed that the age group between 10 and 19 years had the highest prevalence (40%; 95% CI: 29–50; weight 100%). The state with the highest prevalence in this age group was Mato Grosso do Sul (75%), followed by Bahia (50%), Minas Gerais (45%), Sao Paulo (34%), Amazonas (30%), and Pernambuco (6%). In the group over 19 years of age, the pooled prevalence was 34% (95% CI: 20–47; weight 100%). The state with the highest prevalence in this age group was the Federal District (53%), followed by Mato Grosso do Sul (51%), Minas Gerais (47%), Rio Grande do Sul (36%), Pernambuco (35%), Piaui (30%), Rio de Janeiro and Amazonas (26%), Sao Paulo (21%), Bahia (20%), Espirito Santo (19%), and Mato Grosso (9%). Children below 9 years of age had a pooled prevalence of 25% (95% CI: 18–31; weight 100%). The state with the highest prevalence for this age group was Paraiba (85%), followed by Mato Grosso do Sul (55%), Santa Catarina (36%), Mato Grosso and Para (34%), Sergipe (31%), Pernambuco (25%), Minas Gerais (23%), Rio de Janeiro (21%), Sao Paulo (17%), Amazonas (16%), Rio Grande do Sul (15%), Parana and Bahia (13%), and Maranhao and Amapa (4%) (Table 2). The pooled prevalence in the 19,721 male samples was 26% (95% CI: 20–31; weight 100%). The state with the highest prevalence was Para (57%), followed by Pernambuco (33%), Amazonas (28%), Parana (20%), Espirito Santo (19%), Sao Paulo (18%), Mato Grosso and Rio de Janeiro (15%), Minas Gerais (8%), Mato Grosso do Sul (7%), and Bahia (1%). In contrast, the pooled prevalence in the 36,721 female samples was 29% (95% CI: 14–43; weight 100%). The state with the highest prevalence of Entamoeba spp. in female samples was Mato Grosso do Sul (62%), followed by Para (59%), Amazonas (33%), Espirito Santo (31%), Pernambuco (25%), Parana (21%), Sao Paulo (19%), Rio de Janeiro (11%), Minas Gerais (7%), and Mato Grosso (4%). The pooled prevalence in immunosuppressed patients was 18% (95% CI: 7–30; weight 100%). The most prevalent cause of immunosuppression with Entamoeba spp. was cancer (36%), followed by HIV infection (27%), and hemodialysis (10%) (Table 3).
Table 3

Distribution of the pooled prevalence of Entamoeba spp. according to the type of immunosuppression.

ImmunosuppressionOverall subtotal95% CIWeight (%)
Cancer3626–4710.45
HIV infection279–4555.96
Hemodialysis102–1833.59
Overall prevalence187–30100

Abbreviations: 95% CI, 95% confidence interval.

Distribution of the pooled prevalence of Entamoeba spp. according to the type of immunosuppression. Abbreviations: 95% CI, 95% confidence interval.

Entamoeba spp. in animals in Brazil

The 16 studies that analyzed the prevalence of Entamoeba spp. in animals included 3805 coprological tests in different species (79.1% mammals and 20.9% birds). The classification by direct interaction with humans showed that 54% were wild animals in captivity, 2.3% were free-living wild animals, 15.2% were pets, and 28.5% were farm animals. The analysis of prevalence of Entamoeba spp. in Brazilian animals from different orders and with different types of human interaction showed a pooled prevalence of 12% (95% CI: 7–17). Wild animals in captivity had a prevalence of 16% (95% CI: 3–29), free-living wild animals 3% (95% CI: 1–7), farm animals 15% (CI95%: 1–29.00), and pets 6% (95% CI: 1–10) (Fig. 3).
Figure 3

Forest plot for a random-effect meta-analysis of the pooled prevalence of Entamoeba spp. in different animals in Brazil, according to the type of interaction with humans.

Forest plot for a random-effect meta-analysis of the pooled prevalence of Entamoeba spp. in different animals in Brazil, according to the type of interaction with humans. The prevalence of Entamoeba spp. by taxonomic class showed a prevalence of 12% (95% CI: 6–19) in mammals and 6% (95% CI: 1–12) in birds (Table 4).
Table 4

Distribution of the pooled prevalence of Entamoeba spp. according to taxonomic class and interaction with humans.

StudyTaxonomic classOverall prevalence (%)95% CIWeight (%)
Mammals126–1978.60
Guimarães et al. [103]Rodents20–127.05
Chagas et al. [55]Rodents103–295.17
Barbosa et al. [18]Non-human primates3431–367.27
David et al. [68]Non-human primates2314–375.29
Gilioli and Silva [95]Guara wolf2311–404.65
Diniz et al. [71]Anteaters31–87.21
Zanetti et al. [217]Dogs42–67.34
Rosales and Malheiros [173]Dogs1610–236.64
Campos-Filho et al. [45]Dogs10–57.37
Barbosa et al. [17]Pigs2219–257.26
Radavelli et al. [164]Goat21–57.36
Souza et al. [203]Sheep1710–286.01
Birds61–1221.40
Souza et al. [204]Birds229–453.68
Marietto-Gonçalves et al. [132]Birds21–57.35
Freitas et al. [92]Birds75–97.33
Gallo et al. [93]Emus238–503.03
Interaction with humans
Free-living wild animals31–718.08
Captive wild animals163–2936.92
Domestic pets61–1021.35
Domestic farm animals151–2923.66

Abbreviations: 95% CI, 95% confidence interval

Distribution of the pooled prevalence of Entamoeba spp. according to taxonomic class and interaction with humans. Abbreviations: 95% CI, 95% confidence interval Of the captive wild mammals, non-human primates were the most studied, with prevalence percentages of 34% and 23%. In contrast, of the farm mammals, pigs had a prevalence of 22%. Notably, the only animal considered a pet in the studies analyzed was the dog, representing 16% (Table 4). Of the domestic farm birds, emus had a prevalence of 23% and free-living wild birds had a prevalence of 22% (Table 4).

Entamoeba spp. diversity in different host species in Brazil

Conventional microscopy analysis, molecular characterization, serology, and isoenzyme analysis were used to identify Entamoeba spp. in 150 studies, totaling 17,651 human samples. In contrast, only six studies on host animals characterized 51 positive samples at the species level. To calculate the prevalence of the reported species, only the samples that performed this procedure were used. For this purpose, 17,651 samples (fecal and oral cavity) with identification of Entamoeba species, were used. In these samples, the most prevalent species identified in human hosts were E. coli (86.5%), followed by E. dispar (7.9%), E. histolytica (3.1%), E. hartmanni (1.9%), and E. gingivalis 0.6% (Fig. 4). The species identified as non-pathogenic E. histolytica, through zymodeme [2, 3], were considered as E. dispar. On the other hand, E. coli was the only species with a taxonomic classification, identified in animal hosts. In addition, unidentified Entamoeba species were reported in animal hosts.
Figure 4

Geographical distribution of Entamoeba spp. detected in Brazil. (a) Species detected in 17,651 human samples. (b) Species distribution in human and animal hosts according to Brazilian regions. (c) Species distribution in human and animal hosts in Brazilian states. Abbreviations: AC – Acre; AM – Amazonas; RO – Rondonia; PA – Para; MA – Maranhao; PI – Piaui; CE – Ceara; RN – Rio Grande do Norte; PB – Paraiba; PE – Pernambuco; AL – Alagoas; SE – Sergipe; BA – Bahia; MG – Minas Gerais; ES – Espirito Santo; RJ – Rio de Janeiro; SP – Sao Paulo; PR – Parana; SC – Santa Catarina, RS – Rio Grande do Sul; MS – Mato Grosso do Sul; GO – Goias; MT – Mato Grosso; DF – Federal District (Capital of Brazil).

Geographical distribution of Entamoeba spp. detected in Brazil. (a) Species detected in 17,651 human samples. (b) Species distribution in human and animal hosts according to Brazilian regions. (c) Species distribution in human and animal hosts in Brazilian states. Abbreviations: AC – Acre; AM – Amazonas; RO – Rondonia; PA – Para; MA – Maranhao; PI – Piaui; CE – Ceara; RN – Rio Grande do Norte; PB – Paraiba; PE – Pernambuco; AL – Alagoas; SE – Sergipe; BA – Bahia; MG – Minas Gerais; ES – Espirito Santo; RJ – Rio de Janeiro; SP – Sao Paulo; PR – Parana; SC – Santa Catarina, RS – Rio Grande do Sul; MS – Mato Grosso do Sul; GO – Goias; MT – Mato Grosso; DF – Federal District (Capital of Brazil). The prevalence of species by geographical regions showed that E. coli was the most prevalent species in the five regions, with high percentages. Entamoeba histolytica was identified in the north (28.9%), northeast (3.4%), south (1.1%), and southeast (0.3%) regions. The southeast region presented the greatest species diversity, with the identification of the five Entamoeba spp. registered in Brazil, followed by the northeast region with four species, north and south with three, and center-west with two different species (Fig. 4). The detailed distribution of protozoan species by the Brazilian state is shown in Figure 4.

Discussion

Data on the prevalence of Entamoeba spp. were documented in 24 of 26 Brazilian states and in the Federal District. In this meta-analysis, a pooled prevalence of 22% of Entamoeba spp. was found in the Brazilian population. The pooled prevalence was calculated with samples of studies published between 1962 to 2020, so this percentage represents an overall prevalence of Entamoeba spp. in different hosts during this period of time, in Brazil. These results reflect a sampling of the five Brazilian regions, but the northeastern, southern, and southeastern regions are better characterized since these regions present higher scientific production. The northeastern region contributed 38 articles, representing 63.3% of the samples analyzed in this meta-analysis, the southern region 27 studies (16.3%), the southeastern region 62 (12.3%), the northern region 23 (6.7%), and the central-western region 17 studies (1.4%). The analysis of the prevalence of Entamoeba spp. by region showed contrasting realities within the states of each region. The northeastern region showed high pooled prevalence percentages in the states of Paraiba (72%), Ceara (34%), Sergipe (28%), Pernambuco (16%), Piaui (9%) and Bahia (3%). Alagoas and the Rio Grande do Norte showed another reality, with a prevalence of 4% and 2%, respectively. The central-western region showed high pooled prevalence in the Federal District (53%) and the states of Mato Grosso do Sul (35%) and Mato Grosso (34%), but the state of Goias presented a pooled prevalence of 3%. In the northern region, the states of Rondonia (50%), Para (30%), Acre (26%), Amazonas (30%) and Maranhao (19%) showed high percentages of prevalence, while and Amapa showed a prevalence of 4%. In the southeastern region, the states of Espirito Santo, Minas Gerais and Sao Paulo showed a pooled prevalences of 31%, 12% and 11% respectively, while Rio Janeiro presented a moderate prevalence of 9%. The same data were found for the southern region, where the state of Rio Grande do Sul had a high pooled prevalence of 15% and the states Parana and Santa Catarina had a moderate prevalence of 9% and 6%, respectively. The differences in the prevalence of intestinal parasites among the Brazilian regions were recently documented in a previous study [81]. However, in addition to the differences among the regions, this present study showed great prevalence differences within the same region. This epidemiological data can be used as a tool to identify areas of social vulnerability as intestinal parasitosis is strongly associated with the socioeconomic level of the population. In contrast, Brazil is an extensive country and presents many regional and intraregional socioeconomic and health development differences. Only 39% of the cities collect and treat 100% of the sewage [38], with the lack of adequate basic sanitation system increasing the continuous dissemination of neglected diseases linked to sanitary problems, such as intestinal parasitosis, including those caused by Entamoeba spp. Regarding sex, both showed a similar pooled prevalence of Entamoeba spp., with 29% for women and 26% for men, suggesting that sex may not be a determinant for protozoan contamination. Regarding age, there was a high prevalence in the three groups, 40% in the 10–19 years group, 34% in adults aged over 19 years, and 25% in children aged below 9 years. Age is an important risk factor for intestinal parasitic infections. Children are often more susceptible to intestinal infectious diseases than adults owing to inadequate hygiene habits. Children aged below 9 years were the group that presented the highest number of samples analyzed in this meta-analysis, and even though it is the least prevalent for Entamoeba spp., 25% is a percentage of great importance within this population. In contrast, this study showed that the most prevalent group for Entamoeba spp. were the people aged 10–19 years. Therefore, school age represents a higher risk for amebiasis than the age of the general population. A previous study in Indonesia showed a high rate of Entamoeba spp. (52.8%) in the school-age (7–15 years) group [137]. The age group between 10 and 19 years was the most heterogeneous, including pre-adolescents, adolescents, and young adults. However, this group provides a possible panorama for the prevalence of intestinal parasitosis in high school students in Brazil. The pooled prevalence of Entamoeba spp. infection in immunocompromized patients was 18%. This parasitic infection was most prevalent in cancer patients, with 36%, although they presented fewer samples for analysis, followed by HIV and hemodialysis patients, with a prevalence of 27% and 10%, respectively. Some studies indicate that this parasite frequently causes opportunistic infections in immunosuppressed patients [46, 111]; it was one of the most common causes of morbidity in this group. This study recorded high prevalence percentages in immunosuppressed patients, especially with cancer. Cancer, HIV, and hemodialysis patients become immunocompromized as a result of the disease itself or due to therapeutic procedures that cause immunosuppression [134, 193]. Although intestinal parasitic infections are a great risk with persistent diarrhea and severe clinical symptoms in immunocompromized patients, the routine diagnosis of these infections is often ignored during chemotherapy or disease [1, 131]. For this reason, it is extremely important to diagnose and treat parasitic infections to decrease morbidity in this group. The overall pooled prevalence of Entamoeba spp. in animal hosts was 12%. Of these animals, Entamoeba spp. was most prevalent in mammals (12%), followed by birds (6%). Regarding human interaction, Entamoeba spp. was most prevalent in captive wild animals, which are not easily accessible to the general population, followed by domestic farm animals. Farm animal breeding is a possible risk factor for Entamoeba spp. transmission. Therefore, it is necessary to establish control measures to minimize the transmission of these parasites among different animal hosts and humans. For Entamoeba spp. diversity, this study showed little variability in human hosts, with differentiation into five different species. Studies on animal hosts characterized only E. coli. Of the species identified in humans, E. coli was the most prevalent (86.5%), followed by E. dispar (7.9%), E. histolytica (3.1%), E. hartmanni (1.9%), and E. gingivalis (0.6%). The prevalence of these species in Brazil determined in this meta-analysis differed from the world scenario, which presented E. dispar with the highest prevalence (49.4%), followed by E. histolytica (32.3%), E. coli (1.9%), and E. hartmanni (0.9%) [64]. The Brazilian situation could be different if the 89 studies that used conventional identification methods also used molecular analysis in the 5234 samples to separate the species E. dispar from E. histolytica, which are morphologically indistinguishable and were not included in the general percentage. Although this study presents the commensal parasite E. coli as the most prevalent in Brazil, it is important to highlight that this species has the same transmission route as that of other pathogenic species, such as E. histolytica, E. dispar, and even Giardia lamblia as well as helminths. The prevalence of this parasite can be used as an indicator of fecal/oral transmission, suggesting intestinal parasite transmission through water supply for human consumption or through contaminated food. Entamoeba histolytica causes severe intestinal and extraintestinal amebiasis, representing a health risk in countries with inadequate sanitary barriers. This study identified significant prevalence and distribution percentages of E. histolytica in Brazil, with 28.9% prevalence in the north, 3.4% in the northeast, 1.1% in the south, and 0.3% in the southeast. In the central-western region, no study distinguished E. histolytica from E. dispar. It is important to note that more studies need to be developed in this region to resolve this sampling bias. This study has some limitations. First, in human studies, some authors did not distribute the positive sample results by sex and/or age, decreasing the number of classified samples to better evaluate the prevalence by these variables. Second, many samples were not identified at the protozoan species level, which could improve data on the species distribution and prevalence in Brazil, especially those of the pathogenic E. histolytica. Finally, it is recommended that publication biases be evaluated using statistical methods in meta-analyses. However, the currently available methods, such as funnel graphs and the Egger regression test, are not considered useful in proportion studies [147]. In conclusion, this study showed a high prevalence of Entamoeba spp. in the Brazilian population (22%), with a prevalence of up to 50% in the northern, northeastern, and central-western regions. Although there were contrasting prevalence percentages among the regions, there is a wide distribution of Entamoeba spp. in Brazil. There was no difference between males and females, and the age group of 10–19 years had the highest prevalence, broadly indicating the prevalence of intestinal parasitosis in high-school students in Brazil. The most diagnosed species was E. coli, which may suggest the transmission of intestinal parasites through water supply for human consumption or through contaminated food. This may lead to the possibility of infection due to other protozoan pathogenic species. The pathogenic species E. histolytica is distributed in most Brazilian regions, with significant prevalence percentages. The prevalence in mammals was the highest among animals, with interactions among humans and captive, wild, or domestic farm animals presenting the higher protozoan prevalence. The implementation of molecular methods to detect Entamoeba spp. in scientific productions is extremely important to reduce possible false-negatives using coprological methods and to differentiate protozoan species. Patients with any type of immunosuppression should undergo routine intestinal protozoa screening and early treatment to avoid future complications because a significant prevalence was identified in this population.

Conflicts of interest

The authors declare that they have no conflicts of interest.
  130 in total

1.  [Prevalence of Entamoeba histolytica and E ntamoeba hartmanni in the municipality of Ribeirao Preto, Sao Paulo (Brazil)].

Authors:  F FERRIOLLI FILHO
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1962 Sep-Oct       Impact factor: 1.846

2.  Entamoeba histolytica/Entamoeba dispar infection in chronic hemodialysis patients.

Authors:  Sebastiao Rodrigues Ferreira-Filho; Fabiola Corr A da Costa Braga; Danilo Martins de Sa; Evandro Batista Nunes; Juliana Santos Parreira Soares; Silvia Mamprim Padovese; Andreia Camara de Oliveira; Gredista Maria Ferreira Oliveira; Gilberto Dos Passos; H Lton Pereira Lemes
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-03

3.  Gastrointestinal parasites of sheep, municipality of Lajes, Rio Grande do Norte, Brazil.

Authors:  Maria de Fátima de Souza; Manoel Pimentel-Neto; Rízia Maria da Silva; Albeísa Cleyse Batista Farias; Marcos Pezzi Guimarães
Journal:  Rev Bras Parasitol Vet       Date:  2012 Jan-Mar

4.  Enteroparasitosis and their ethnographic relationship to food handlers in a tourist and economic center in Paraná, Southern Brazil.

Authors:  Maria das Graças Marciano Hirata Takizawa; Dina Lúcia Morais Falavigna; Mônica Lúcia Gomes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Jan-Feb       Impact factor: 1.846

5.  Development and evaluation of molecular tools for detecting and differentiating intestinal amoebae in healthy individuals.

Authors:  Amal Chihi; Christen R Stensvold; Imene Ben-Abda; Rania Ben-Romdhane; Karim Aoun; Emna Siala; Aïda Bouratbine
Journal:  Parasitology       Date:  2019-01-14       Impact factor: 3.234

6.  Relationship between intestinal parasitic infection in children and soil contamination in an urban slum.

Authors:  Fernando Korkes; Fabiane U Kumagai; Rubens N Belfort; Denis Szejnfeld; Thiago G Abud; Ana Kleinman; Gabriela M Florez; Tania Szejnfeld; Pedro P Chieffi
Journal:  J Trop Pediatr       Date:  2008-05-22       Impact factor: 1.165

7.  [Intestinal parasitism in a Parakanã indigenous community in southwestern Pará State, Brazil].

Authors:  R A Miranda; F B Xavier; R C Menezes
Journal:  Cad Saude Publica       Date:  1998 Jul-Sep       Impact factor: 1.632

8.  Intestinal parasites among employees of restaurants and cafeterias in a city of Brazil.

Authors:  Alline M Nunes Wildemberg Brauer; Janaína Costa da Silva; Anelise Andrade de Souza; Marco Antônio Andrade de Souza
Journal:  Rev Salud Publica (Bogota)       Date:  2017 Sep-Oct

9.  Molecular typing of Giardia duodenalis isolates from nonhuman primates housed IN a Brazilian zoo.

Authors:  Érica Boarato David; Mariella Patti; Silvana Torossian Coradi; Teresa Cristina Goulart Oliveira-Sequeira; Paulo Eduardo Martins Ribolla; Semíramis Guimarães
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

10.  Possible pathogenicity of commensal Entamoeba hartmanni revealed by molecular screening of healthy school children in Indonesia.

Authors:  Takahiro Matsumura; Joko Hendarto; Tetsushi Mizuno; Din Syafruddin; Hisao Yoshikawa; Makoto Matsubayashi; Taro Nishimura; Masaharu Tokoro
Journal:  Trop Med Health       Date:  2019-01-15
View more
  2 in total

1.  Fast screening of enteropathogens in marine water samples.

Authors:  Carmen Baur Vieira; Irene Trigueiros Araújo; Fernando César Ferreira; Jie Liu; Renato Castiglia Feitosa; Marize Pereira Miagostovich
Journal:  Braz J Microbiol       Date:  2022-05-21       Impact factor: 2.214

2.  Molecular Characterization of Entamoeba spp. in Pigs with Diarrhea in Southern China.

Authors:  Pei Wang; Sen Li; Yang Zou; Ru-Yi Han; Ping Wang; De-Ping Song; Cheng-Bin Wang; Xiao-Qing Chen
Journal:  Animals (Basel)       Date:  2022-07-09       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.